Trend
DailyUptrend (starting)
4 hourStrong Bearish
1 hourBearish
15 minAscending Triangle
5 minStrong Bullish
Daily trend turns down below $0.64
Key levels
Resistance$1.90
Resistance$1.67
Support$1.30
Support$1.12
Latest news & SEC filings
No headlines in the last 90 days.
Zhengye Biotechnology is a holding company incorporated in the Cayman Islands that carries out its business through subsidiaries based in China. The company operates in the biotechnology sector, with a Hong Kong subsidiary named Peg Biotechnology. Its shares trade on a U.S. exchange, and it is subject to Chinese regulations governing overseas listings and data security.
Based on the company's 20-F filed Apr 28, 2026.
Nasdaq · Healthcare
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ZYBT.
Start Free Trial →Valuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
31
Moat Score
NONE
4/9
Piotroski Score
N/A
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
ACCUMULATING
Short Squeeze Risk
LOW
Signal: NEUTRAL
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
-11.9%
3yr Revenue CAGR
-4.5%
EPS Growth YoY
N/A
FCF Growth YoY
-63.7%
Revenue Trend
DECLINING
SEPT Investing tracks real-time dark pool institutional trades for ZYBT, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 13:32:15 | $1.44 | 5,999 | $$9K | SELL |
| 14:40:18 | $1.51 | 3,000 | $$5K | BUY |
| 18:36:14 | $1.53 | 1,880 | $$3K | BUY |
| 18:31:54 | $1.46 | 1,990 | $$3K | SELL |
| 17:21:43 | $1.56 | 1,890 | $$3K | BUY |
5 dark pool trades shown · $$22K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for Zhengye Biotechnology Holding Ltd (ZYBT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →Zhengye Biotechnology Holding Ltd (ZYBT) is at $1.52, down 1.30% (-$0.02) at the Nov 11, 2026 close.
ZYBT does not currently pay a dividend.
Zhengye Biotechnology Holding Ltd reported $86M of debt and $19M of cash (Dec 31, 2024).
Support: $1.30, $1.12, $0.85. Resistance: $1.67, $1.90, $2.11.
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.